Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD-LIVE: Live vaccines to induce innate immune training in COPD
2023-504519-34-01Phase 2Completed
- Sponsor
- Gentofte Hospital
- Start
- Feb 2024
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of M-M-R II and bcg vaccine in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Gentofte Hospital. Primary endpoint: Innate immune training from baseline to 4 months. Started Feb 2024; status: completed.
02
Drugs
M-M-R IIbcg vaccine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2023-504519-34-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504519-34-01.